Moderate Coffee Consumption Slashes Dementia Risk by 35%, Landmark Study Reveals
A massive long-term study has found that drinking two to three cups of coffee each day is linked to a 35% lower risk of developing dementia, with the strongest protection observed in people under age 75. The findings, published Tuesday, add to growing evidence that a simple daily habit could have profound brain benefits.
Researchers analyzed data from over 300,000 participants followed for more than a decade. They discovered that moderate coffee drinkers had significantly fewer cases of Alzheimer's disease and other dementias compared to those who drank little or no coffee.
"The protective effect appears to be strongest before age 75, suggesting that coffee consumption may be especially important for preventing early-onset dementia," said Dr. Sarah Jenkins, lead author of the study at the University of Oxford. "We believe caffeine helps keep brain cells active while reducing inflammation and the buildup of harmful amyloid plaques."
Background
The study, part of the UK Biobank project, tracked participants' coffee intake through dietary questionnaires and health records. Researchers accounted for factors like age, smoking, exercise, and diet to isolate coffee's effect.
Previous studies have hinted at coffee's neuroprotective properties, but this is one of the largest to quantify the risk reduction. The team also examined decaf coffee but found no significant association, pointing to caffeine as a key driver.
"Caffeine may work by blocking adenosine receptors in the brain, which reduces inflammation and oxidative stress," explained Dr. Michael Torres, a neurologist at Johns Hopkins University who was not involved in the study. "But the dose matters—too much coffee can have the opposite effect."
What This Means
The findings suggest that moderate coffee consumption—around two to three cups per day—could be a simple, low-cost strategy for reducing dementia risk. However, experts caution that the effect plateaus after that amount, and excessive intake (over five cups) may increase anxiety, insomnia, or heart issues.
"More coffee is not better," Dr. Jenkins emphasized. "We saw that the protective benefit leveled off after moderate intake. Stick to two to three cups, and avoid loading it with sugar or cream."
For people under 75, the study offers a potential way to support long-term brain health. But researchers stress that coffee should be part of a broader healthy lifestyle, including diet, exercise, and social engagement.
"Coffee alone won't prevent dementia, but it's a promising addition to our prevention toolkit," said Dr. Torres. "This study gives us another reason to feel good about that morning cup."
The results also highlight the need for more research into how caffeine interacts with the aging brain. Future studies could explore genetic differences in caffeine metabolism and whether other compounds in coffee contribute to the effect.
For now, the takeaway is clear: a moderate coffee habit may be a simple step toward cognitive resilience. As the global population ages, such strategies become increasingly vital.
This is a breaking news update. Additional details may emerge as the study is reviewed by other scientists.